Literature DB >> 16045739

Circulating anti-actin and anti-ATP synthase antibodies identify a sub-set of patients with idiopathic nephrotic syndrome.

L Musante1, G Candiano, M Bruschi, L Santucci, B Carnemolla, P Orecchia, M Giampuzzi, C Zennaro, S Sanna-Cherchi, M Carraro, R Oleggini, G Camussi, F Perfumo, G M Ghiggeri.   

Abstract

Idiopathic nephrotic syndrome (iNS) with resistance or dependence to steroids is a common disease in children but in spite of an increasing clinical impact its pathogenesis is unknown. We screened for the presence of circulating antibodies against glomerular (podocytes, mesangium) and tubular cells (tubular epithelia) a cohort of 60 children with iNS including 8 patients with a familial trait of iNS or with proven mutation of NPHS1-NPHS2 and 12 with good sensitivity to steroids. Positive sera were found in 8 cases, all belonging to the category without familial trait/molecular defects. The targets of antibodies were characterized with Western blot and MALDI-Mass utilizing beta-hexyl cell extracts separated with two-dimensional electrophoresis. In all cases antibodies of the IgM class were directed against ATP synthase beta chain alone (4 cases) or in combination with actin (3 cases); one child presented IgG against aldose reductase. The clinical picture was nephrotic syndrome with steroid resistance or dependence and variable cyclosporin sensitivity; 3 patients developed end stage renal failure. The basic pathology picture was focal segmental glomerulosclerosis (FSGS) in 4 cases and mesangial proliferative glomerulonephrites with deposition of IgM in 2. Overall, patients with circulating auto-antibodies could not be readely differentiated on clinical grounds with the exception of 3 children who developed positivity for antinuclear antibodies during the follow-up. Affinity-purified IgM from one patient who underwent plasmapheresis for therapeutical pourposes (but not from a normal pool) induced proteinuria in Sprague-Dawley rats and concomitant human IgM deposition within glomeruli. This is the first report of circulating anti-actin/ATP synthase beta chain antibodies in a subset of patients with iNS. Both pathological significance and clinical impact given by the presence of these antibodies and the relationship with other conditions such as lupus-erythematosus, characterized by their presence, must be defined.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16045739      PMCID: PMC1809461          DOI: 10.1111/j.1365-2249.2005.02862.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

Review 1.  Cellular penetration and nuclear localization of anti-DNA antibodies: mechanisms, consequences, implications and applications.

Authors:  M P Madaio; K Yanase
Journal:  J Autoimmun       Date:  1998-10       Impact factor: 7.094

2.  Deposition of anti-actin antibodies in the kidney of a patient with systemic lupus erythematosus under immunosuppressive treatment.

Authors:  A Boulila; J Hachicha; F Z Adyel; R Jlidi; S Avrameas; T Ternynck; H Ayadi
Journal:  Nephrol Dial Transplant       Date:  1996-12       Impact factor: 5.992

Review 3.  Glomerular cell culture.

Authors:  G E Striker; L J Striker
Journal:  Lab Invest       Date:  1985-08       Impact factor: 5.662

4.  Distinct pathogenic effects of group B coxsackieviruses on human glomerular and tubular kidney cells.

Authors:  P G Conaldi; L Biancone; A Bottelli; A De Martino; G Camussi; A Toniolo
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  Autoantibodies from mixed cryoglobulinaemia patients bind glomerular antigens.

Authors:  M P Dolcher; B Marchini; A Sabbatini; G Longombardo; C Ferri; L Riente; S Bombardieri; P Migliorini
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

6.  Quantitative two-dimensional protein electrophoresis for studies of inborn errors of metabolism.

Authors:  C R Merril; D Goldman
Journal:  Clin Chem       Date:  1982-04       Impact factor: 8.327

7.  Alpha-enolase is a renal-specific antigen associated with kidney involvement in mixed cryoglobulinemia.

Authors:  A Sabbatini; M P Dolcher; B Marchini; D Chimenti; S Moscato; F Pratesi; S Bombardieri; P Migliorini
Journal:  Clin Exp Rheumatol       Date:  1997 Nov-Dec       Impact factor: 4.473

Review 8.  Primary focal segmental glomerulosclerosis: clinical course and response to therapy.

Authors:  S M Korbet; M M Schwartz; E J Lewis
Journal:  Am J Kidney Dis       Date:  1994-06       Impact factor: 8.860

9.  Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome.

Authors:  J Dantal; E Bigot; W Bogers; A Testa; F Kriaa; Y Jacques; B Hurault de Ligny; P Niaudet; B Charpentier; J P Soulillou
Journal:  N Engl J Med       Date:  1994-01-06       Impact factor: 91.245

10.  Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis.

Authors:  V J Savin; R Sharma; M Sharma; E T McCarthy; S K Swan; E Ellis; H Lovell; B Warady; S Gunwar; A M Chonko; M Artero; F Vincenti
Journal:  N Engl J Med       Date:  1996-04-04       Impact factor: 91.245

View more
  12 in total

1.  A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation.

Authors:  Marianne Delville; Tara K Sigdel; Changli Wei; Jing Li; Szu-Chuan Hsieh; Alessia Fornoni; George W Burke; Patrick Bruneval; Maarten Naesens; Annette Jackson; Nada Alachkar; Guillaume Canaud; Christophe Legendre; Dany Anglicheau; Jochen Reiser; Minnie M Sarwal
Journal:  Sci Transl Med       Date:  2014-10-01       Impact factor: 17.956

Review 2.  Focal segmental glomerular sclerosis: do not overlook the role of immune response.

Authors:  Francesco Reggiani; Claudio Ponticelli
Journal:  J Nephrol       Date:  2016-02-20       Impact factor: 3.902

3.  Antimitochondrial autoantibodies in pemphigus vulgaris: a missing link in disease pathophysiology.

Authors:  Steve Marchenko; Alexander I Chernyavsky; Juan Arredondo; Vivian Gindi; Sergei A Grando
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

Review 4.  Idiopathic nephrotic syndrome: the EBV hypothesis.

Authors:  Claire Dossier; Agnès Jamin; Georges Deschênes
Journal:  Pediatr Res       Date:  2016-09-28       Impact factor: 3.756

5.  Prevalence of herpesviruses at onset of idiopathic nephrotic syndrome.

Authors:  Claire Dossier; Anne-Laure Sellier-Leclerc; Alexandra Rousseau; Yanne Michel; Agnès Gautheret-Dejean; Mariana Englender; Fouad Madhi; Marina Charbit; Tim Ulinski; Tabassome Simon; Evelyne Jacqz-Aigrain; Georges Deschênes
Journal:  Pediatr Nephrol       Date:  2014-06-05       Impact factor: 3.714

Review 6.  The glomerular permeability factors in idiopathic nephrotic syndrome.

Authors:  Jean-Claude Davin
Journal:  Pediatr Nephrol       Date:  2015-04-30       Impact factor: 3.714

7.  A repertoire of 124 potential autoantigens for autoimmune kidney diseases identified by dermatan sulfate affinity enrichment of kidney tissue proteins.

Authors:  Wei Zhang; Jung-Hyun Rho; Michael W Roehrl; Michael H Roehrl; Julia Y Wang
Journal:  PLoS One       Date:  2019-06-25       Impact factor: 3.240

Review 8.  FSGS Recurrence in Adults after Renal Transplantation.

Authors:  Michael Rudnicki
Journal:  Biomed Res Int       Date:  2016-04-10       Impact factor: 3.411

9.  Autoantibody signatures defined by serological proteome analysis in sera from patients with cholangiocarcinoma.

Authors:  Mohammad Zahid Mustafa; Viet Hung Nguyen; François Le Naour; Eleonora De Martin; Elvire Beleoken; Catherine Guettier; Catherine Johanet; Didier Samuel; Jean-Charles Duclos-Vallee; Eric Ballot
Journal:  J Transl Med       Date:  2016-01-16       Impact factor: 5.531

10.  Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS.

Authors:  Sophie Doublier; Cristina Zennaro; Luca Musante; Tiziana Spatola; Giovanni Candiano; Maurizio Bruschi; Luca Besso; Massimo Cedrino; Michele Carraro; Gian Marco Ghiggeri; Giovanni Camussi; Enrico Lupia
Journal:  PLoS One       Date:  2017-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.